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Abstract
OBJECTIVE—To estimate trends in good perinatal outcomes (singleton live births at term with 
birthweight more than 2,500 g) among live births after assisted reproductive technology in the 
United States from 2000 to 2008, and associated factors among singletons in 2008.
METHODS—Using retrospective cohort data from the National Assisted Reproductive 
Technology Surveillance System from 2000 to 2008, we calculated relative change and χ2 tests for 
trend in the proportion of good perinatal outcomes among assisted reproductive technology live 
births (n=444,909) and liveborn singletons (n=222,500). We conducted univariable analyses 
followed by multiple logistic regression to estimate the effects of various characteristics on the 
outcome among singletons born in 2008 after fresh, nondonor assisted reproductive technology 
cycles (n=20,780).
RESULTS—The proportion of good perinatal outcomes among all liveborn neonates increased 
from 38.6% in 2000 to 42.5% in 2008, whereas it declined marginally among singletons from 
83.6% to 83.4%. One previous birth, transfer of fewer than three embryos, and the presence of 
fewer than three fetal hearts on 6-week ultrasound examination were associated with good 
perinatal outcome among singletons. Non-Hispanic black race, tubal factor infertility, uterine 
factor infertility, ovulatory disorder, and 5-day embryo culture were associated with reduced odds 
for a good outcome. The strongest association was the presence of one fetal heart compared with 
more than two (adjusted odds ratio 2.43, 95% confidence interval 1.73–3.42).
CONCLUSION—From 2000 to 2008, good perinatal outcomes increased among assisted 
reproductive technology live births. Among singleton live births, odds for good outcome were 
greatest with the presence of a single fetal heart and lowest in women of non-Hispanic black race.
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Assisted reproductive technology, fertility treatment that involves oocyte retrieval, 
laboratory handling of gametes, and the transfer of embryos or gametes into the fallopian 
tubes or uterus, has become increasingly utilized since its inception in 1978. In 2008, there 
were 61,430 neonates born after assisted reproductive technology, representing more than 
1% of all United States births.1 Although pregnancy and live birth rates after assisted 
reproductive technology continue to increase, those born after assisted reproductive 
technology have increased risks of preterm delivery, low birthweight, and perinatal 
mortality.2–5
Although a portion of the increased risk of adverse pregnancy outcomes is attributable to the 
increased incidence of multiple gestations with assisted reproductive technology, studies 
have consistently demonstrated elevated risks of preterm delivery and low birthweight in 
singletons conceived after assisted reproductive technology in comparison with those in the 
general population.6–13 Some studies conclude that adverse outcomes result from an assisted 
reproductive technology treatment effect.14–17 Others suggest that underlying infertility, 
older age, chronic illness, primiparity, and other characteristics unique to women 
undergoing assisted reproductive technology play a significant role.13,18–24 Moreover, some 
studies are inconclusive or suggest that underlying characteristics of women undergoing 
assisted reproductive technology and treatment factors affect outcomes to a similar 
degree.25–28
American Society for Reproductive Medicine guidelines regarding embryo transfer as well 
as numerous research studies, commentaries, and developments in the field have changed 
the practice of assisted reproductive technology over the past decade, leading physicians to 
transfer fewer embryos when appropriate. We conducted analyses of the Centers for Disease 
Control and Prevention National Assisted Reproductive Technology Surveillance System to 
estimate how the proportion of good perinatal outcomes has changed among the United 
States assisted reproductive technology birth cohort from 2000 to 2008. To identify possible 
predictors of good perinatal outcomes after assisted reproductive technology, we further 
analyzed a subset of births from the most recent year, 2008.
MATERIALS AND METHODS
Data used in this study were obtained from National Assisted Reproductive Technology 
Surveillance System, which collects information about assisted reproductive technology 
cycles performed at United States fertility assisted reproductive technology clinics, as 
mandated by law (Fertility Clinic Success Rate and Certification Act of 1992, Public Law 
No. 102-493, October 24, 1992). Assisted reproductive technology procedures include those 
involving the laboratory handling of gametes, namely in vitro fertilization (IVF) 
transcervical embryo transfer, gamete intrafallopian transfer, and zygote intrafallopian 
transfer. National Assisted Reproductive Technology Surveillance System data include 
patient demographics, patient obstetrical and medical history, parental infertility diagnosis, 
clinical parameters of the assisted reproductive technology procedure, and information 
regarding resultant pregnancies and births. Approximately 5–12% of assisted reproductive 
technology clinics did not report data to Centers for Disease Control and Prevention during 
2000–2008. Because most nonreporting clinics are small, we estimate that National Assisted 
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Reproductive Technology Surveillance System contains information about more than 95% 
of all assisted reproductive technology cycles performed in the United States.
In vitro fertilization transcervical embryo transfer can be categorized further into the 
following groups: 1) fresh, donor; 2) fresh, nondonor; 3) frozen, donor; and 4) frozen, 
nondonor. Cycles involving fresh embryos are defined as those in which embryos were 
transferred after embryo culture. Cycles involving frozen embryos are defined as those in 
which thawed, previously frozen embryos were transferred. Donor embryo transfer refers to 
the transfer of donor embryos, whereas nondonor embryo transfer refers to the transfer of 
the patient’s own embryos.
We used data on all live births resulting from assisted reproductive technology cycles 
performed between 2000 and 2008 for the analysis of trends in good perinatal outcomes 
among all assisted reproductive technology live births (n=444,909) and among the subset of 
assisted reproductive technology liveborn singletons (n=222,500). Because we wanted to 
estimate the effects of factors other than multiple births on perinatal outcomes, we limited 
our analyses to singleton live births resulting from fresh, nondonor IVF transcervical 
embryo transfer cycles performed in 2008 (n=21,451), thereby ensuring homogeneity of the 
study population. We excluded 483 neonates for whom data were unavailable on birthweight 
or gestational age and 188 neonates born to gestational carriers. Our final study population 
for this analysis consisted of 20,780 neonates.
We defined a “good perinatal outcome” to be the live birth of a singleton neonate born at 
term (37 or more completed weeks of gestation) weighing 2,500 g or more. For fresh 
embryo transfers, we calculated gestational age by subtracting the date of oocyte retrieval 
from the date of birth and adding 14 days to adjust for theoretical last menstrual period. For 
assisted reproductive technology cycles involving transfer of previously frozen embryos, 
and in cases in which the date of oocyte retrieval was missing, we calculated gestational age 
by subtracting the date of embryo transfer from the date of birth and adding 17 days to 
adjust for theoretical last menstrual period and days in embryo culture.
All statistical analyses were performed using SAS statistical software 9.2. We estimated 
trends in proportion of good perinatal outcomes among all assisted reproductive technology 
live births and assisted reproductive technology singleton live births from 2000 to 2008 
using χ2 test for trend among the following cycle groups: fresh, nondonor; fresh, donor; 
frozen, nondonor; and frozen, donor. For each of these groups, we calculated the relative 
change in proportion of good perinatal outcomes from 2000 to 2008 and computed a χ2 test 
for trend.
We examined the distribution of maternal and treatment characteristics for liveborn 
singletons and for all liveborn neonates after fresh, nondonor assisted reproductive 
technology cycles initiated in 2008. For singletons, univariable analyses were conducted to 
evaluate associations with good perinatal outcome with the χ2 test for differences in 
proportions for the following characteristics: maternal age; gravidity; previous births; race or 
ethnicity; parental infertility diagnosis; use of intracytoplasmic sperm injection; use of 
assisted hatching; availability of supernumerary embryos for freezing; number of embryos 
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transferred; number of fetal hearts on 6-week ultrasound examination; number of days of 
embryo culture; history of spontaneous abortion; and history of assisted reproductive 
technology cycles. Race or ethnicity data were missing for more than 30% of all assisted 
reproductive technology births. To allow use of data for these births, we created a category 
of “unknown” for those with missing data for the race or ethnicity variable. Because patients 
may have had more than one infertility diagnosis, the presence or absence of each diagnosis 
was handled as an individual variable.
Factors that were determined to be significant based on univariable analysis (P<.05) were 
included in a logistic regression model to describe predictors of good perinatal outcome. We 
used stepwise multiple logistic regression and included only those variables that had a two-
tailed P<.05 in the final model. We calculated the adjusted odds ratios (ORs) and 
accompanying 95% confidence intervals (CIs) for each term. We also calculated a χ2 
statistic for goodness-of-fit on the final model, which indicated an adequate fit.
We conducted sensitivity analyses using multiple logistic regression in the manner 
described, limiting the original sample of 2008 liveborn singletons after fresh, nondonor 
assisted reproductive technology to those with: 1) one fetal heart on 6-week ultrasound 
examination (n=17,289); 2) one embryo transferred (n=2,128); and 3) nonmissing data 
(n=13,613) for the race or ethnicity variable. Additionally, we repeated univariable analysis 
for tubal factor infertility, limiting this group to those solely with tubal factor infertility 
diagnosed (n=3,376) compared with all others (n=17,404).
Last, to assess the validity of our results among the population of assisted reproductive 
technology live births, we conducted separate analyses to assess associations with good 
outcomes among the population of all live births after 2008 fresh, nondonor assisted 
reproductive technology cycles (n=40,288). We used univariable analyses for the factors 
described and defined good perinatal outcomes as live births at 37 completed weeks or 
more, with birth-weights of at least 2,500 g. In addition to these factors, we tested singleton 
compared with nonsingleton live birth for association with the outcome. Factors determined 
to be significant were included in a stepwise logistic regression model controlling for 
clustering effects of mothers with multiple birth outcomes by incorporating a random effects 
model. This study was approved by the Institutional Review Board of the Centers for 
Disease Control and Prevention.
RESULTS
The total number of liveborn neonates conceived after assisted reproductive technology 
increased 76%, from 34,861 in 2000 to 61,430 in 2008 (Table 1). Similarly, the number of 
liveborn singleton neonates conceived after assisted reproductive technology increased 95% 
during the same time period. The percentage of good perinatal outcomes among all assisted 
reproductive technology liveborn neonates increased from 38.6% in 2000 to 42.5% in 2008 
(P<.05). An increase in good perinatal outcomes among all assisted reproductive technology 
live births was observed in all assisted reproductive technology cycle groups, with a 
significant trend (P<.05) for all with the exception of frozen, donor cycles. The percentage 
of good perinatal outcomes among all singleton live births, however, declined slightly from 
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83.6% in 2000 to 83.4% in 2008. In addition, there was a small decline in good perinatal 
outcomes among liveborn singletons in the fresh, nondonor cycle group from 84.1% to 
83.9%. A decline also was observed in the frozen, nondonor cycle group, although a 
significant trend was not detected (P=0.13). Some year-to-year variation was seen for the 
other cycle types, but overall the percentages of births with good perinatal outcomes 
changed little, with no significant trend detected.
The study population chosen to investigate factors associated with good perinatal outcomes
—singleton neonates born after fresh, nondonor IVF transcervical embryo transfer in 2008 
(n=20,780)—was similar in most characteristics to all liveborn neonates after fresh, 
nondonor IVF transcervical embryo transfer from the same year (Table 2), but was 
substantially different with respect to the frequency of good perinatal outcomes. The greatest 
differences between the two groups were observed in the proportion of neonates born at or 
after 37 weeks of gestation (87% of singletons and 62% of all liveborn neonates) and with a 
birthweight of at least 2,500 g (90% of singletons and 66% of all liveborn neonates). For 
both groups, most neonates were born to women 30–39 years of age and to women with no 
previous births. Approximately half of the neonates in both groups were born to women with 
one or more previous pregnancies. Although more than 30% of reported assisted 
reproductive technology cycles did not contain data for the race or ethnicity variable, most 
neonates for whom maternal race was reported were born to women of non-Hispanic white 
race. The most common infertility diagnosis in both groups was male factor, and uterine 
factor was the least common diagnosis. For both groups, in most procedures, 
intracytoplasmic sperm injection was used and use of assisted hatching was less common. 
Availability of supernumerary embryos for cryopreservation after assisted reproductive 
technology cycles was somewhat less common among singleton neonates (44%) than for all 
liveborn neonates (49%). Ten percent of singleton live births, and 6% of all live births, 
resulted from the transfer of a single embryo. Two or more fetal hearts were observed much 
less commonly in the assisted reproductive technology singleton group, and the assisted 
reproductive technology singleton group had a smaller proportion of embryos transferred on 
day 5 (at blastocyst stage). The groups were similar in terms of number of previous 
spontaneous abortions and number of previous assisted reproductive technology cycles.
Results of univariable analyses indicated that one previous birth, the transfer of one or two 
embryos compared with more than two, and the presence of one or two fetal hearts on 6-
week ultrasound examination compared with more than two hearts were associated with 
good perinatal outcomes (Table 3). All of these associations remained significant in the final 
multiple logistic regression model. Non-Hispanic black race, tubal factor infertility, uterine 
factor infertility, ovulatory disorder, and 5 days of embryo culture were inversely associated 
with good perinatal outcomes in the final model. The strongest positive association with 
good perinatal outcome was estimated for the presence of one fetal heart on 6-week 
ultrasound examination as compared with more than two fetal hearts (adjusted OR 2.4, 95% 
CI 1.7–3.4), and the strongest negative association was estimated for non-Hispanic black as 
compared with non-Hispanic white race (adjusted OR 0.5, 95% CI 0.4–0.6). Limiting the 
sample to those with one heart on 6-week ultrasound examination (n=17,289) did not change 
the other associations retained in the final model to any appreciable extent (results not 
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shown). When we limited the sample to those with one embryo transferred (n=2,128), most 
of the associations were in the same direction as observed in the original analysis, although 
not significant (results not shown). However, the transfer of blastocyst stage embryos was 
not associated with the outcome (adjusted OR 1.0, CI 0.8–1.4) in this additional analysis.
To assess the effect of the missing race or ethnicity data on our results, we limited the 
sample to those with nonmissing data (n=13,613). Most of the observed associations were 
retained in the final model (results not shown), with effect estimates more than 1.0 observed 
for one previous birth, the presence of fewer fetal hearts on 6-week ultrasound examination, 
and the transfer of one embryo; the effect estimate for tubal factor infertility remained less 
than 1.0. Most notably, one fetal heart on 6-week ultrasound examination remained the 
strongest predictor of good outcomes (adjusted OR 1.7, 95% CI 1.1–2.7) and non-Hispanic 
black race remained the strongest negative predictor (adjusted OR 0.5, 95% CI 0.4–0.6).
Because we did not expect tubal factor infertility to be inversely associated with good 
outcomes, we investigated this in greater detail. Because the groups of fertility diagnosis 
were not mutually exclusive, we repeated univariable analysis, comparing those solely 
diagnosed with tubal factor infertility (n=3,376) with all others (n=17,404), and association 
with the outcome was retained (results not shown).
Last, we tested for associations with good outcomes among all assisted reproductive 
technology live births in 2008 after fresh, nondonor assisted reproductive technology and 
found that most observed associations were retained in the final model, with effect estimates 
more than 1.0 for one previous birth, the presence of fewer fetal hearts on 6-week ultrasound 
examination, and the transfer of one embryo; the effect estimates for non-Hispanic black 
race, tubal factor infertility, ovarian disorder, and transfer of blastocyst stage embryo were 
less than 1.0. The presence of one fetal heart had the strongest association with good 
outcomes (adjusted OR 48.0, 95% CI 40.9–56.3) and non-Hispanic black race remained the 
strongest negative predictor (adjusted OR 0.6, 95% CI 0.5–0.7). Additionally, maternal age 
older than 30 was associated with good outcomes in this analysis. We also found that there 
were fewer multiple births in older women despite increased numbers of embryos being 
transferred.
DISCUSSION
Traditionally, success in assisted reproductive technology has been viewed as clinical live 
birth. More recently, it has been suggested that success should be defined as the birth of a 
healthy singleton.29 We report an increase in good perinatal outcomes among all assisted 
reproductive technology live births from 2000 to 2008, a finding that likely reflects changes 
in the practice of assisted reproductive technology in the United States. After the first 
publication of American Society for Reproductive Medicine guidelines regarding embryo 
transfer in 1998 and 1999, the numbers of embryos transferred decreased sharply in the 
subsequent years.30 Between 2000 and 2008, the percentage of fresh, nondonor IVF cycles 
that involved the transfer of a single embryo increased from less than 1% to 10%.1 Although 
techniques and practices may have changed, singletons born after assisted reproductive 
technology remain at risk for adverse outcomes.
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In our analysis, the strongest predictor of good outcomes was the presence of a single fetal 
heart. This finding is consistent with a recent analysis that demonstrated that spontaneous 
losses increase the odds for preterm birth and low birthweight in singletons.31 Furthermore, 
we found that transferring fewer embryos resulted in better outcomes.
Race was also an important predictor of perinatal outcomes. A recent large analysis 
regarding racial disparities in assisted reproductive technology with respect to birth 
outcomes reported increased risks for low birthweight and preterm delivery among 
singletons born to non-Hispanic black women.32 Although the reasons for racial disparity in 
assisted reproductive technology remain unclear, we found non-Hispanic black race to be 
strongly associated with a lower likelihood of good perinatal outcomes.
Uterine factor infertility, ovulatory disorders, tubal factor infertility, and embryo transfer 
after 5 days of embryo culture were inversely associated with good perinatal outcome. Tubal 
disease may alter the intrauterine environment during pregnancy. In a study of patients using 
donor oocytes, hydrosalpinges in the recipient were associated with higher miscarriage and 
ectopic pregnancy rates,33 and a larger meta-analysis demonstrated that early pregnancy loss 
was more common in assisted reproductive technology patients with hydrosalpinx among 
those with tubal factor infertility.34
Our analysis of national surveillance data should be considered in light of its strengths and 
limitations. The use of nationwide surveillance data provides increased statistical power and 
the restriction of our analysis to data from 1 year decreases the chances that our results are 
affected by changes in assisted reproductive technology.
Our findings regarding race should be interpreted with caution given that more than 30% of 
data regarding maternal race were missing. However, the similarity in the effect estimates 
for the unknown and the non-Hispanic white race or ethnicity groups, the lack of a change in 
our finding for non-Hispanic black race on restriction of the analyses to nonmissing data, 
and the fact that most women who undergo assisted reproductive technology are of non-
Hispanic white race suggest that those for whom race or ethnicity data were missing were 
mostly non-Hispanic white women. Sufficient data were unavailable to examine the effects 
of body mass index, chronic disease, socioeconomic status, and behavioral or lifestyle 
characteristics on outcomes. Last, our study describes factors associated with outcomes 
among singleton live births and should be interpreted with this in mind.
These results demonstrate that good perinatal outcomes among singleton births after fresh, 
nondonor IVF are predicted by multiple factors. Single embryo transfer was associated with 
superior outcomes, whereas non-Hispanic black race was associated with less favorable 
outcomes. Future work is needed to investigate the mechanisms behind these effects and to 
identify reasons for racial disparities to improve outcomes.
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Table 2
Distribution of 2008 Liveborn Neonates After Fresh, Nondonor In Vitro Fertilization Transcervical Embryo 
Transfer by Characteristics
Characteristic
Liveborn Singletons After Fresh, 
Nondonor IVF Transcervical Embryo 
Transfer
Liveborn Neonates After Fresh, Nondonor 
IVF Transcervical Embryo Transfer
Total 20,780 40,228
Birthweight (g)
 Less than 2,500 2,017 (9.7) 13,501 (33.6)
 At least 2,500 18,763 (90.3) 26,727 (66.4)
Gestational age at delivery (wk)
 At least 37 18,071 (87.0) 24,997 (62.1)
 Less than 37 2,709 (13.0) 15,231 (37.9)
Maternal age (y)
 Younger than 30 3,372 (16.2) 7,277 (18.0)
 30–34 7,815 (37.6) 16,239 (40.4)
 35–39 7,531 (36.2) 13,679 (34.0)
 40–44 2,048 (9.9) 3,010 (7.5)
 45 or older 14 (0.1) 23 (0.1)
No. of previous pregnancies
 0 9,877 (47.6) 19,472 (48.5)
 1 5,442 (26.3) 10,493 (26.1)
 2 or more 5,420 (26.1) 10,192 (25.4)
No. of previous births
 0 14,735 (71.5) 28,756 (69.8)
 1 4,437 (21.5) 8,391 (22.7)
 2 or more 1,446 (7.0) 2,781 (7.5)
Race or ethnicity
 Unknown 7,617 (36.7) 14,584 (36.3)
 Non-Hispanic white 10,143 (48.8) 19,861 (49.4)
 Non-Hispanic black 674 (3.2) 1,306 (3.2)
 Hispanic 994 (4.8) 2,057 (5.1)
 Asian or Pacific Islander 1,352 (6.5) 2,420 (6.0)
Infertility diagnosis*
 Tubal factor 3,376 (16.3) 6,686 (16.6)
 Endometriosis 2,614 (12.6) 5,320 (13.2)
 Uterine factor 734 (3.5) 1,376 (3.4)
 Ovulatory disorder 3,489 (16.8) 7,196 (17.9)
 Diminished ovarian reserve 2,864 (13.8) 4,756 (11.8)
 Male factor 8,263 (39.8) 16,317 (40.6)
Use of ICSI†
 Yes 15,047 (72.5) 28,898 (71.9)
 No 5,720 (27.5) 11,303 (28.1)
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Characteristic
Liveborn Singletons After Fresh, 
Nondonor IVF Transcervical Embryo 
Transfer
Liveborn Neonates After Fresh, Nondonor 
IVF Transcervical Embryo Transfer
Use of assisted hatching‡
 Yes 7,536 (36.3) 13,674 (34.0)
 No 13,244 (63.7) 26,554 (66.0)
No. of supernumerary embryos cryopreserved
 Unknown 102 (0.5) 165 (0.4)
 0 11,623 (56.2) 20,428 (51.0)
 1 or more 9,055 (43.8) 19,635 (49.0)
No. of embryos transferred
 1 2,128 (10.2) 2,211 (5.5)
 2 11,856 (57.1) 24,288 (60.4)
 3 or more 6,796 (32.7) 13,729 (34.1)
No. of fetal hearts on 6-wk ultrasound scan
 1 18,914 (91.4) 18,996 (47.9)
 2 1,618 (7.8) 18,364 (46.3)
 3 or more 174 (0.8) 2,278 (5.8)
No. of days of embryo culture
 Unknown and all others 1,592 (7.7) 2,875 (7.2)
 5 8,621 (41.5) 18,241 (45.3)
 3 10,567 (50.9) 19,112 (47.5)
No. of previous spontaneous abortions
 0 14,723 (70.9) 28,817 (71.6)
 1 or more 6,057 (29.2) 11,411 (28.4)
No. of previous ART cycles
 0 12,923 (62.2) 25,456 (63.3)
 1 3,791 (18.2) 7,080 (17.6)
 2 or more 4,066 (19.6) 7,688 (19.1)
IVF, in vitro fertilization; ICSI, intracytoplasmic sperm injection; ART, assisted reproductive technology.
Data are n or n (%).
*
Percentages do not add up to 100 because the groups are not mutually exclusive (one patient may have multiple diagnoses).
†
Refers to the direct injection of sperm into an oocyte for the purpose of improving chances of fertilization.
‡
Refers to treatments in which a minor defect is created in the zona pellucida for the purpose of improving chances of implantation.
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Table 3
Predictors of Good Perinatal Outcomes Among 2008 Singleton Live Births Resulting From Fresh, Nondonor 
In Vitro Fertilization Intracervical Embryo Transfer
Characteristic
% Liveborn 
Singletons With Good 
Perinatal Outcome
Unadjusted Odds Ratio 
(95% CI)




 Younger than 30 83.3 1.00
 30–34 84.4 1.09 (0.98–1.21)
 35–39 84.5 1.09 (0.98–1.22)
 40–44 84.0 1.05 (0.90–1.22)
 45 or older 92.9 2.61 (0.34–19.97)
No. of previous pregnancies
 0 84.2 1.00
 1 85.0 1.06 (0.97–1.17)
 2 or more 83.4 0.95 (0.87–1.04)
No. of previous births
 0 83.8 1.00 1.00
 1 86.0 1.19 (1.09–1.31) 1.19 (1.08–1.32) <.01
 2 or more 82.6 0.92 (0.80–1.06) 0.95 (0.81–1.10)
Race or ethnicity
 Non-Hispanic black 73.7 0.49 (0.41–0.59) 0.53 (0.43–0.64) <.01
 Hispanic 82.2 0.81 (0.68–0.96) 0.86 (0.72–1.05)
 Asian or Pacific Islander 82.9 0.85 (0.73–0.99) 0.89 (0.74–1.04)
 Unknown 84.4 0.95 (0.87–1.03) 0.93 (0.85–1.01)
 Non-Hispanic white 85.1 1.00 1.00
Infertility diagnosis
 Tubal factor 81.8 0.81 (0.74–0.89) 0.82 (0.74–0.92) <.01
 No tubal factor 84.7 1.00 1.00
 Endometriosis 84.8 1.05 (0.94–1.18)
 No endometriosis 84.1 1.00
 Uterine factor 79.7 0.73 (0.60–0.87) 0.77 (0.64–0.94)
 No uterine factor 84.4 1.00 1.00
 Ovulatory disorder 81.1 0.77 (0.70–0.84) 0.73 (0.66–0.81)
 No ovulatory disorder 84.8 1.00 1.00
 Diminished ovarian reserve 84.0 0.98 (0.88–1.10)
 No diminished ovarian reserve 84.3 1.00
 Male factor 84.7 1.07 (0.99–1.15)
 No male factor 83.9 1.00
Use of ICSI†
 Yes 84.3 1.01 (0.93–1.10)
 No 84.1 1.00
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Characteristic
% Liveborn 
Singletons With Good 
Perinatal Outcome
Unadjusted Odds Ratio 
(95% CI)
Adjusted Odds Ratio* 
(95% CI) P*
Use of assisted hatching‡
 Yes 84.3 1.01 (0.94–1.09)
 No 84.2 1.00
No. of supernumerary embryos 
cryopreserved
 0 84.6 1.00
 1 or more 83.7 0.93 (0.86–1.00)
No. of embryos transferred
 1 85.8 1.20 (1.04–1.37) 1.27 (1.09–1.48) <.01
 2 84.4 1.08 (0.99–1.17) 1.18 (1.08–1.29)
 3 or more 83.4 1.00 1.00
No. of fetal hearts on 6-wk ultrasound scan
 1 84.9 2.27 (1.63–3.16) 2.43 (1.73–3.42) <.01
 2 77.5 1.39 (0.98–1.97) 1.49 (1.04–2.13)
 3 or more 71.3 1.00 1.00
No. of days of embryo culture
 5 83.2 0.88 (0.82–0.95) 0.86 (0.79–0.94) <.01
 3 85.0 1.00 1.00
No. of previous spontaneous abortions
 0 84.5 1.00
 1 or more 83.4 0.92 (0.85–1.00)
No. of previous ART cycles
 0 84.4 1.00
 1 83.8 0.96 (0.87–1.06)
 2 or more 84.2 0.99 (0.90–1.09)
CI, confidence interval; ICSI intracytoplasmic sperm injection; ART, assisted reproductive technology.
*
For those variables included in the final model.
†
Refers to the direct injection of sperm into an oocyte for the purpose of improving chances of fertilization.
‡
Refers to treatments in which a minor defect is created in the zona pellucida for the purpose of improving chances of implantation.
Obstet Gynecol. Author manuscript; available in PMC 2015 June 03.
